Asthma Clinical Trials in Los Angeles

Showing 321-340 of 340 trials

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

NCT00024544

The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.

Asthma

Facet Biotech120 participantsStarted Aug 2001

Los Angeles, California, United States • Mission Viejo, California, United States • Orange, California, United States +15 more locations

COMPLETEDPhase 3< 1 mile

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

NCT00073840

The primary objective of this study is to investigate the efficacy of levalbuterol 90 ug (2 actuations, 45 ug each) versus placebo (2 actuations) in the treatment and prevention of bronchoconstriction in adolescent and adult subjects with asthma, with all treatments administered 4 times a day (QID).

Asthma

Sumitomo Pharma America, Inc.386 participantsStarted Dec 2002

Oxford, Alabama, United States • Tucson, Arizona, United States • Corona, California, United States +51 more locations

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Asthma Trials in Other Cities

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma

Efficacy and Safety of Different Doses of Indacaterol

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

Non-invasive Measures of Effects of Xolair in Asthma

A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects

Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury

Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Study of Daclizumab in Patients With Chronic, Persistent Asthma

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Other Conditions in Los Angeles